The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy
Authors:
Open Access
- 27 April 2023
- journal article
- research article
- Published by Springer Nature in Neurology and Therapy
- Vol. 12 (3) , 961-976
Abstract
Introduction Spinal muscular atrophy (SMA) can cause multiple system dysfunction, especially lipid metabolic disorders, for which management strategies are currently lacking. Microbes are related to metabolism and the pathogenesis of neurological diseases. This study aimed to preliminarily explore the alterations in the gut microbiota in SMA and the potential relationship between altered microbiota and lipid metabolic disorders. Methods Fifteen patients with SMA and 17 gender- and age-matched healthy controls were enrolled in the study. Feces and fasting plasma samples were collected. 16S ribosomal RNA sequencing and nontargeted metabolomics analysis were performed to explore the correlation between microbiota and differential lipid metabolites. Results No significant difference was found in microbial diversity (α- and β-diversity) between the SMA and control groups, with both groups having a relatively similar community structure. However, compared to the control group, the SMA group showed an increased relative abundance of the genera Ruminiclostridium, Gordonibacter, Enorma, Lawsonella, Frisingicoccus, and Anaerofilum and a decreased abundance of the genera Catabacter, Howardella, Marine_Methylotrophic_Group_3, and Lachnospiraceae_AC2044_group. The concurrent metabolomic analysis showed that the SMA group had 56 different kinds of lipid metabolite levels than did the control group. Additionally, the Spearman correlation suggested a correlation between the altered differential lipid metabolites and the above-mentioned altered microbiota. Conclusions The gut microbiome and lipid metabolites differed between the patients with SMA and the control subjects. The altered microbiota may be related with the lipid metabolic disorders in SMA. However, further study is necessary to clarify the mechanism of lipid metabolic disorders and develop management strategies to improve the related complications in SMA.Keywords
Funding Information
- National Natural Science Foundation (82271735)
- Key R&D Program of Zhejiang Province (2022C03167)
- Zhejiang Province Public Welfare Technology Application Research Project (LGC21H090001)
- Key Technologies Research and Development Program of Zhejiang Province (2021C03099)
- Scientific Research Fund of Zhejiang University (XY2022045)
This publication has 41 references indexed in Scilit:
- Linoleic acid and the pathogenesis of obesityProstaglandins & Other Lipid Mediators, 2016
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- Linoleic AcidAdvances in Nutrition, 2013
- Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risksEuropean Journal of Paediatric Neurology, 2012
- FLASH assembly of TALENs for high-throughput genome editingNature Biotechnology, 2012
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Using ecological diversity measures with bacterial communitiesFEMS Microbiology Ecology, 2003
- Estimating the Number of Species in a Stochastic Abundance ModelBiometrics, 2002
- BIOTIN INMETABOLISM ANDMOLECULARBIOLOGYAnnual Review of Nutrition, 2002
- Metabolism of palmitaldehyde in human cardiac muscle—ii. Fatty chain elongation and shorteningInternational Journal of Biochemistry, 1982